Norchelerythrine from Corydalis incisa (Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia
International Journal of Oncology · 2025
DOI: 10.3892/ijo.2025.5723 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Ji-Eun Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, DNA Damage, Corydalis, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is the most prevalent form of leukemia in adults.The cornerstone of first-line chemotherapy for AML has poor survival rates, underscoring the urgent need for development of novel therapeutic agents.Differentiation therapy targets the blockade of differentiation in myeloid progenitor cells.The present study screened 100 plant extracts native to South Korea to search for those with differentiation-inducing activity in AML.Differentiation-inducing activity was assessed by measuring CD11b expression using fluorescence activated cell sorting.Of these, Corydalis incisa (Thunb.)Pers.(CIP) exhibited the highest efficacy.CIP induced myeloid differentiation, decreased viability and increased cell apoptosis and cell cycle arrest in HL-60, U937 and THP-1 cells.Furthermore, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry identified norchelerythrine as the primary anti-leukemic compound in CIP.Norchelerythrine induced differentiation and promoted cell cycle arrest and apoptosis, mirroring the tumor-suppressive effects of CIP, and notably decreased cell viability in patients with various genetic abnormalities.The present mechanistic study showed that norchelerythrine stimulated reactive oxygen species generation, leading to activation of DNA damage signaling and upregulation of p21 cip1 , a cyclin-dependent kinase inhibitor.Overall, norchelerythrine isolated from CIP may be a novel therapeutic option in AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea.
- Department of Molecular and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
- Korea Research Institute of Standard and Science, Daejeon 34113, Republic of Korea.
- Division of Hematology‑Oncology, Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan 46241, Republic of Korea.
Zitieren
APA
Lee, J. E., Jeon, B. E., Kwon, C. S., Kim, H. Y., Kim, T. J., Seo, Y., Lee, S. H., Shin, H. J., & Kim, S. W. (2025). Norchelerythrine from Corydalis incisa (Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia. International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5723
Vancouver
Lee JE, Jeon BE, Kwon CS, Kim HY, Kim TJ, Seo Y, et al. Norchelerythrine from Corydalis incisa (Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia. International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5723
BibTeX
@article{Lee2025,
author = {Lee, Ji-Eun and Jeon, Byeol-Eun and Kwon, Chan-Seong and Kim, Hyeon-Young and Kim, Tae-Jin and Seo, Youngseob and Lee, Sang Hun and Shin, Ho-Jin and Kim, Sang-Woo},
title = {Norchelerythrine from Corydalis incisa (Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia},
journal = {International Journal of Oncology},
year = {2025},
doi = {10.3892/ijo.2025.5723}
}
EUVIMED